Catalyst Wire Dossier Catalyst Wire Dossier

Sacituzumab Govitecan

sacituzumab govitecan · Gilead Sciences
Drug timelines are a Plus or Pro feature.

66 regulatory and trial events tracked for Sacituzumab Govitecan, covering 2021-04-30 to 2026-06-02. Get the full timeline:

Most recent: Clinical Trial Results: Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread [Phase 3]

See pricing